Wang Hao, Paul Jenny, Ye Ivana, Blalock Jake, Wiener R Constance, Ho Amy F, Alanis Naomi, Sambamoorthi Usha
Department of Emergency Medicine, JPS Health Network, 1500 S. Main St., Fort Worth, TX 76104, USA.
Texas College of Osteopathic Medicine, University of North Texas Health Science Center, 3500 Camp Bowie Blvd, Fort Worth, TX 76107, USA.
J Affect Disord Rep. 2022 Apr;8:100331. doi: 10.1016/j.jadr.2022.100331. Epub 2022 Feb 22.
During the coronavirus 2019 (COVID-19) pandemic, increased anxiety and depression were reported, with mixed findings among individuals of different races/ethnicities. This study examines whether anxiety and depression increased during the COVID-19 pandemic compared to the pre-COVD-19 period among different racial/ethnic groups in the US.
The Health Information National Trend Surveys 5 (HINTS 5) Cycle 4 data was analyzed. We used the time when the survey was administered as the pre-COVID-19 period (before March 11, 2020, weighted = 77,501,549) and during the COVID-19 period (on and after March 11, 2020, weighted = 37,222,019). The Patient Health Questionnaire (PHQ) was used to measure anxiety/depression and further compared before and during COVID-19. Separate multivariable logistic regression analyses were used to determine the association of the COVID-19 pandemic with anxiety/depression after adjusting for age, sex, insurance, income, and education.
A higher percentage of Non-Hispanic whites (NHW) with chronic conditions reported anxiety (24.3% vs. 11.5%, = 0.0021) and depression (20.7% vs. 9.3%, = 0.0034) during COVID-19 than pre-COVID-19. The adjusted odds ratio (AOR) of anxiety and depression for NHWs with chronic conditions during the COVID-19 pandemic was 2.02 (95% confidence interval of 1.10-3.73, = 0.025) and 2.33 (1.17-4.65, = 0.018) compared to NHWs who participated in the survey before the COVID-19.
Limited to the NHW US population. PHQ can only be used as the initial screening tool.
The COVID-19 pandemic was associated with an increased prevalence of anxiety and depression among NHW adults with chronic conditions, but not among people of color.
在2019年冠状病毒病（COVID-19）大流行期间，有报告称焦虑和抑郁情绪有所增加，不同种族/族裔个体的研究结果不一。本研究旨在探讨与COVID-19大流行前相比，美国不同种族/族裔群体在COVID-19大流行期间焦虑和抑郁情绪是否有所增加。
分析了美国国家健康信息趋势调查5（HINTS 5）第4轮数据。我们将调查实施时间分为COVID-19大流行前时期（2020年3月11日前，加权人数=77,501,549）和COVID-19大流行期间（2020年3月11日及之后，加权人数=37,222,019）。使用患者健康问卷（PHQ）来测量焦虑/抑郁情绪，并在COVID-19大流行前后进行进一步比较。在调整年龄、性别、保险、收入和教育因素后，分别采用多变量逻辑回归分析来确定COVID-19大流行与焦虑/抑郁情绪之间的关联。
与COVID-19大流行前相比，患有慢性病的非西班牙裔白人（NHW）在COVID-19大流行期间报告焦虑情绪的比例更高（24.3%对11.5%，P=0.0021），报告抑郁情绪的比例也更高（20.7%对9.3%，P=0.0034）。与在COVID-19大流行前参与调查的NHW相比，患有慢性病的NHW在COVID-19大流行期间焦虑和抑郁的调整优势比（AOR）分别为2.02（95%置信区间为1.10-3.73，P=0.025）和2.33（1.17-4.65，P=0.018）。
仅限于美国NHW人群。PHQ仅可作为初步筛查工具。
COVID-19大流行与患有慢性病的NHW成年人中焦虑和抑郁患病率的增加有关，但与有色人种无关。
